Literature DB >> 7956594

Erythromycin enhances gastric emptying in patients with gastroparesis after vagotomy and antrectomy.

B Ramirez1, E Y Eaker, W E Drane, M P Hocking, C A Sninsky.   

Abstract

We studied the effect of erythromycin on gastric emptying in nine patients with gastroparesis following truncal vagotomy and antrectomy, and assessed their clinical response to chronic oral erythromycin. Gastric emptying was evaluated using a solid-phase radio-labeled meal. Patients were studied after erythromycin 200 mg intravenously (N = 9) and after an oral suspension of erythromycin 200 mg (N = 7) each given 15 min after ingestion of the meal. Three parameters of gastric emptying were analyzed: half-emptying time (T1/2), area under the curve, and percent gastric residual at 2 hr. Nine patients were subsequently placed on oral suspension erythromycin 150 mg three times a day before meals (range 125-250 mg three times a day) and symptoms of nausea, vomiting, postprandial fullness, and abdominal pain were assessed before and after erythromycin. Intravenous erythromycin markedly accelerated the gastric emptying (all three parameters studied) of solids (P < 0.01) in seven of nine patients with postsurgical gastroparesis [baseline T1/2 154 +/- 15 min; after intravenous erythromycin, T1/2 56 +/- 17 min (mean +/- SEM)]. Oral erythromycin enhanced (P < 0.05) the gastric emptying rate (T1/2, area under the curve) in five of seven patients (baseline T1/2 146 +/- 16 min; after oral erythromycin, T1/2 87 +/- 20 min). Of the nine patients who were placed on oral maintenance erythromycin, three showed clinical improvement after two weeks. In summary, erythromycin significantly enhances gastric emptying in many patients with vagotomy and antrectomy-induced gastroparesis; however, only a small subset of patients respond clinically to chronic oral erythromycin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7956594     DOI: 10.1007/BF02087641

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

1.  Erythromycin and gastroparesis.

Authors:  R B Christian; A R Cooke
Journal:  Kans Med       Date:  1990-10

2.  An erythromycin derivative, EM-523, induces motilin-like gastrointestinal motility in dogs.

Authors:  N Inatomi; H Satoh; Y Maki; N Hashimoto; Z Itoh; S Omura
Journal:  J Pharmacol Exp Ther       Date:  1989-11       Impact factor: 4.030

3.  Erythromycin is a motilin receptor agonist.

Authors:  T Peeters; G Matthijs; I Depoortere; T Cachet; J Hoogmartens; G Vantrappen
Journal:  Am J Physiol       Date:  1989-09

4.  Gastrointestinal motor effects of erythromycin.

Authors:  M F Otterson; S K Sarna
Journal:  Am J Physiol       Date:  1990-09

5.  Comparison of methods for analyzing gastric isotope emptying.

Authors:  M C Dugas; R R Schade; D Lhotsky; D Van Thiel
Journal:  Am J Physiol       Date:  1982-09

6.  Analysis of gastric emptying data.

Authors:  J D Elashoff; T J Reedy; J H Meyer
Journal:  Gastroenterology       Date:  1982-12       Impact factor: 22.682

7.  Erythromycin induces migrating motor complex in human gastrointestinal tract.

Authors:  T Tomomasa; T Kuroume; H Arai; K Wakabayashi; Z Itoh
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

Review 8.  Erythromycin: a motilin agonist and gastrointestinal prokinetic agent.

Authors:  F H Weber; R D Richards; R W McCallum
Journal:  Am J Gastroenterol       Date:  1993-04       Impact factor: 10.864

9.  Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies.

Authors:  J Janssens; T L Peeters; G Vantrappen; J Tack; J L Urbain; M De Roo; E Muls; R Bouillon
Journal:  N Engl J Med       Date:  1990-04-12       Impact factor: 91.245

10.  Nausea, vomiting, and abdominal pain after Roux-en-Y anastomosis: motility of the jejunal limb.

Authors:  J R Mathias; A Fernandez; C A Sninsky; M H Clench; R H Davis
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

View more
  8 in total

1.  Acute Intestinal Pseudo-obstruction.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-08

2.  The effect of erythromycin on gastrointestinal motility in subtotal gastrectomized patients.

Authors:  A-Lan Lee; Choong-Bai Kim
Journal:  J Korean Surg Soc       Date:  2012-02-27

Review 3.  Gastroparesis: current diagnostic challenges and management considerations.

Authors:  Shamaila Waseem; Baharak Moshiree; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

Review 4.  Childhood gastroparesis is a unique entity in need of further investigation.

Authors:  Liz Febo-Rodriguez; Bruno P Chumpitazi; Robert J Shulman
Journal:  Neurogastroenterol Motil       Date:  2019-08-13       Impact factor: 3.598

5.  Premedication with erythromycin improves endoscopic visualization of the gastric mucosa in patients with subtotal gastrectomy: a prospective, randomized, controlled trial.

Authors:  Byoung Yeon Jun; Myung-Gyu Choi; Jong Yul Lee; Myong-Ki Baeg; Sung Jin Moon; Chul-Hyun Lim; Jin Su Kim; Yu Kyung Cho; In Seok Lee; Sang Woo Kim; Kyu Yong Choi
Journal:  Surg Endosc       Date:  2014-01-01       Impact factor: 4.584

6.  Diabetic Gastroparesis.

Authors:  Adil E Bharucha; Yogish C Kudva; David O Prichard
Journal:  Endocr Rev       Date:  2019-10-01       Impact factor: 19.871

7.  Erythromycin dose of 70 mg accelerates gastric emptying as effectively as 200 mg in the critically ill.

Authors:  Marc A Ritz; Marianne J Chapman; Robert J Fraser; Mark E Finnis; Ross N Butler; Patricia Cmielewski; Geoffrey P Davidson; Deborah Rea
Journal:  Intensive Care Med       Date:  2005-06-07       Impact factor: 17.440

Review 8.  Gastrointestinal motility after digestive surgery.

Authors:  Erito Mochiki; Takayuki Asao; Hiroyuki Kuwano
Journal:  Surg Today       Date:  2007-11-26       Impact factor: 2.549

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.